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The authors have retracted this article because there is an 
inconsistency in the preferred model (model 4). This will 
lead to the worst health state (55555) receiving a higher 
value than 55455 and will obviously affect the values of 
other health states as well. All authors agree with this retrac-
tion. The authors have been invited to submit a new manu-
script using a different model for peer review.
The original article can be found online at https:// doi. org/ 10. 1007/ 
s40273- 021- 01002-z.
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